Top Markets
#1 Asteroid Shiba Asteroid Shiba +111,233.42%
#2 Moonriver Moonriver +185.52%
#3 inSure DeFi inSure DeFi +124.89%
#4 Lorenzo stBTC Lorenzo stBTC +78.86%
#5 Metis Metis +45.51%
#6 SOON SOON +41.81%
#7 tomiNet tomiNet +41.49%
#8 Sapien Sapien +35.31%
#9 Audius Audius +33.12%
#10 ZetaChain ZetaChain +21.23%
Coin of the day
Asteroid Shiba Asteroid Shiba
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Classement en actions #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Prix de l'action
$9.13
Capitalisation boursière
$39.27K
Changement (1 jour)
0.00%
Changement (1 an)
-11.76%
Pays
IE
Échange Malin Corporation plc (MLC)

Catégorie

Healthcare
Revenus pour Malin Corporation plc (MLC)
Revenus en Dec 2025 TTM : 0.00
Selon les derniers rapports financiers de Malin Corporation plc, le chiffre d'affaires actuel de l'entreprise (TTM) est de 0.00. En 2023, l'entreprise a réalisé un chiffre d'affaires de 0.00 égal à le chiffre d'affaires de l'année 2022, qui était de 0.00. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Malin Corporation plc de 2015 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 -100.00%
2020 $49.93M 27.52%
2019 $39.16M -10.33%
2018 $43.67M -13.14%
2017 $50.28M 13.50%
2016 $44.30M 78.15%
2015 $24.87M 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 $4.43B -
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 $24.76B -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 $28.60B -
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 $9.47B -
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.31B -
IN